NCT02547662 2023-10-30Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell LeukemiaMayo ClinicPhase 2 Completed17 enrolled 13 charts
NCT03591744 2018-12-19Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell LeukemiaCity of Hope Medical CenterPhase 1 Withdrawn